189 related articles for article (PubMed ID: 23568857)
21. Influence of Acyclic Nucleoside Phosphonate Antivirals on Gene Expression of Chemokine Receptors CCR5 and CXCR4.
Potměšil P; Holý A; Zídek Z
Folia Biol (Praha); 2015; 61(1):1-7. PubMed ID: 25958305
[TBL] [Abstract][Full Text] [Related]
22. Some novel aminopropyl nucleoside phosphonates.
Zhou D; Lagoja IM; Van Aerschot A
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):563-6. PubMed ID: 18066856
[TBL] [Abstract][Full Text] [Related]
23. Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro.
Hartline CB; Gustin KM; Wan WB; Ciesla SL; Beadle JR; Hostetler KY; Kern ER
J Infect Dis; 2005 Feb; 191(3):396-9. PubMed ID: 15633099
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of novel acyclic nucleoside phosphonates against human and animal gammaherpesviruses revealed an altered metabolism of cyclic prodrugs upon Epstein-Barr virus reactivation in P3HR-1 cells.
Coen N; Duraffour S; Naesens L; Krecmerová M; Van den Oord J; Snoeck R; Andrei G
J Virol; 2013 Nov; 87(22):12422-32. PubMed ID: 24027315
[TBL] [Abstract][Full Text] [Related]
25. 6-[2-phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity.
Balzarini J; Pannecouque C; Naesens L; Andrei G; Snoeck R; De Clercq E; Hocková D; Holý A
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1321-7. PubMed ID: 15571252
[TBL] [Abstract][Full Text] [Related]
26. Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities.
Ying C; Holy A; Hocková D; Havlas Z; De Clercq E; Neyts J
Antimicrob Agents Chemother; 2005 Mar; 49(3):1177-80. PubMed ID: 15728921
[TBL] [Abstract][Full Text] [Related]
27. [Advances in the study of nucleoside antiviral drugs].
Liu K; Xie L
Yao Xue Xue Bao; 2006 Aug; 41(8):689-93. PubMed ID: 17039770
[No Abstract] [Full Text] [Related]
28. Phosphonomethoxyalkyl analogs of nucleotides.
Holy A
Curr Pharm Des; 2003; 9(31):2567-92. PubMed ID: 14529543
[TBL] [Abstract][Full Text] [Related]
29. The discovery of antiviral agents: ten different compounds, ten different stories.
De Clercq E
Med Res Rev; 2008 Nov; 28(6):929-53. PubMed ID: 18438800
[TBL] [Abstract][Full Text] [Related]
30. In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA.
Dal Pozzo F; Andrei G; Lebeau I; Beadle JR; Hostetler KY; De Clercq E; Snoeck R
Antiviral Res; 2007 Jul; 75(1):52-7. PubMed ID: 17184854
[TBL] [Abstract][Full Text] [Related]
31. Antiviral acyclic nucleoside phosphonates structure activity studies.
Holý A
Antiviral Res; 2006 Sep; 71(2-3):248-53. PubMed ID: 16857275
[TBL] [Abstract][Full Text] [Related]
32. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.
Hostetler KY
Antiviral Res; 2009 May; 82(2):A84-98. PubMed ID: 19425198
[TBL] [Abstract][Full Text] [Related]
33. Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.
Roux L; Priet S; Payrot N; Weck C; Fournier M; Zoulim F; Balzarini J; Canard B; Alvarez K
Eur J Med Chem; 2013 May; 63():869-81. PubMed ID: 23603046
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antiviral activity evaluation of acyclic 2'-azanucleosides bearing a phosphonomethoxy function in the side chain.
Koszytkowska-Stawińska M; De Clercq E; Balzarini J
Bioorg Med Chem; 2009 Jun; 17(11):3756-62. PubMed ID: 19442526
[TBL] [Abstract][Full Text] [Related]
35. Expedient synthesis and biological evaluation of alkenyl acyclic nucleoside phosphonate prodrugs.
Pileggi E; Serpi M; Andrei G; Schols D; Snoeck R; Pertusati F
Bioorg Med Chem; 2018 Jul; 26(12):3596-3609. PubMed ID: 29880251
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of antiviral drug resistance of vaccinia virus: identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs.
Gammon DB; Snoeck R; Fiten P; Krecmerová M; Holý A; De Clercq E; Opdenakker G; Evans DH; Andrei G
J Virol; 2008 Dec; 82(24):12520-34. PubMed ID: 18842735
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonates.
Prichard MN; Hartline CB; Harden EA; Daily SL; Beadle JR; Valiaeva N; Kern ER; Hostetler KY
Antimicrob Agents Chemother; 2008 Dec; 52(12):4326-30. PubMed ID: 18852272
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of acyclic nucleoside phosphonates.
Holý A
Curr Protoc Nucleic Acid Chem; 2005 Oct; Chapter 14():Unit 14.2. PubMed ID: 18428938
[TBL] [Abstract][Full Text] [Related]
39. Antiviral activities of novel 5-phosphono-pent-2-en-1-yl nucleosides and their alkoxyalkyl phosphonoesters.
Choo H; Beadle JR; Kern ER; Prichard MN; Keith KA; Hartline CB; Trahan J; Aldern KA; Korba BE; Hostetler KY
Antimicrob Agents Chemother; 2007 Feb; 51(2):611-5. PubMed ID: 17130297
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiviral evaluation of cyclopentyl nucleoside phosphonates.
Wang M; Srivastava P; Liu C; Snoeck R; Andrei G; De Jonghe S; Herdewijn P
Eur J Med Chem; 2018 Apr; 150():616-625. PubMed ID: 29550734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
